中西医结合治疗后循环缺血性眩晕合并高血压临床观察  

Clinical Observation of Circulating Ischemic Vertigo Combined with Hypertension After Integrated Treatment of Traditional Chinese and Western Medicine

作　　者：王会磊 裴媛[2] WANG Huilei;PEI Yuan(Graduate School of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,China;The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang,110032,China)

机构地区：[1]辽宁中医药大学研究生学院,辽宁沈阳110032 [2]辽宁中医药大学附属医院,辽宁沈阳110032

出　　处：《中国医药指南》2022年第13期120-122,126,共4页Guide of China Medicine

摘　　要：目的研究后循环缺血性眩晕合并高血压患者实施天麻钩藤饮+硝苯地平控释片治疗的效果。方法纳入2019年12月至2021年2月我院收治的后循环缺血性眩晕合并高血压患者86例为研究对象。参照组(43例)实施硝苯地平控释片治疗,研究组(43例)实施天麻钩藤饮+硝苯地平控释片治疗。研究治疗2个月后的临床治疗总有效率、舒张压、收缩压、中医证候积分、眩晕障碍调查表(DHI)评分值、Hcy水平、椎基底动脉的收缩期峰值血流速度(Vs)值、搏动指数(PI)值、不良反应发生率。结果治疗2个月后,研究组的临床治疗总有效率95.35%、椎基底动脉Vs值(37.79±4.78)cm/s,同参照组的79.07%、(32.55±4.02)cm/s比较更高(P<0.05);治疗2个月后,研究组的舒张压值(80.76±6.44)mm Hg、收缩压值(126.38±9.80)mm Hg、中医证候积分(7.50±3.76)分、DHI量表评分(20.51±3.35)分、血浆Hcy值(10.09±3.36)μmol/L、PI值(0.63±0.02),同参照组的(131.59±8.93)mm Hg、(83.85±6.07)mm Hg、(9.57±3.73)分、(35.91±4.13)分、(12.02±3.37)μmol/L、(1.06±0.15)比较均更低(P<0.05);治疗2个月后,研究组的不良反应发生率6.99%,同参照组的9.31%比较而言,无统计学意义(P>0.05)。结论天麻钩藤饮+硝苯地平控释片用于后循环缺血性眩晕合并高血压患者治疗中的效果更佳,可明显控制病情,提高治疗效果,有效调节椎基底动脉血流指标,且不增加不良反应发生率。Objective To study the effect of tianma gouteng decoction+nifedipine controlled-release tablets in patients with posterior circulation ischemic vertigo and hypertension.Methods From December 2019 to February 2021,86 patients with posterior circulation ischemic vertigo and hypertension who were treated in our hospital were included as the research objects.The program of the reference group(43 cases)implementation of nifedipine controlled-release tablets,and the research group(43 cases)implementation of tianma gouteng decoction+nifedipine controlledrelease tablets.The total effective rate of clinical treatment,diastolic blood pressure,systolic blood pressure,TCM syndrome score,vertigo disorder questionnaire(DHI)score,Hcy level the systolic peak value of vertebrobasilar artery blood flow velocity(Vs)value,pulsatility index(PI)value,incidence of adverse reactions after 2 months of study treatment.Results After 2 months of treatment,the total effective rate of clinical treatment in the research group was 95.35%,and the Vs value of the vertebral basilar artery was(37.79±4.78)cm/s,which was the same as that of the reference group of 79.07%,(32.55±4.02)cm/s was higher(P<0.05).After 2 months of treatment,the diastolic blood pressure value(80.76±6.44)mm Hg,the systolic blood pressure value(126.38±9.80)mm Hg,the TCM syndrome score(7.50±3.76)points,DHI scale score(20.51±3.35)points,plasma Hcy value(10.09±3.36)μmol/L,PI value(0.63±0.02),the same as the reference group(131.59±8.93)mm Hg,(83.85±6.07)mm Hg,(9.57±3.73)points,(35.91±4.13)points,(12.02±3.37)μmol/L,(1.06±0.15)were all lower(P<0.05).After 2 months of treatment,the incidence of adverse reactions in the research group was 6.99%,which was not statistically significant compared with 9.31%in the reference group(P>0.05).Conclusion Tianma gouteng decoction+nifedipine controlled-release tablets has better effect in the treatment of patients with posterior circulation ischemic vertigo and hypertension,which can significantly control the disease,improve the tre

关 键 词：天麻钩藤饮 硝苯地平控释片 后循环缺血性眩晕 高血压 椎基底动脉 不良反应 

分 类 号：R544.1[医药卫生—心血管疾病]